Abstract
Background and aims It is important to determine an accurate demarcation line (DL) between the cancerous lesions and background mucosa in magnifying narrow-band imaging (M-NBI)-based diagnosis. However, it is difficult for novice endoscopists. Recently, machine learning (ML) approaches such as deep learning have been applied to this issue; however, this results in the burden of training ML models and labeling large datasets. To overcome these issues, we propose and a DL determination system using an unsupervised ML method.
Methods Our method consists of the following four steps: 1) An M-NBI image is segmented into superpixels (a group of neighboring pixels) using simple linear iterative clustering. 2) The image features are extracted for each superpixel. 3) The superpixels are grouped into several clusters using k-means method. 4) The boundaries of the clusters are extracted as DL candidates. To validate the proposed method, 16 M-NBI images of 4 cases were used for performance evaluation. The evaluation investigated the similarity of the DLs identified by endoscopists and our method, and the Euclidean distance between the two DLs was calculated.
Results The average Euclidean distances for the four cases were 13.07, 19.95, 12.53, and 17.90. The results indicated that the specific selection of the number of clusters enabled the proposed method to detect DLs that were similar to those of the endoscopists. The DLs identified by our method represented the complex shapes of the DLs, similarly to those identified by experienced doctors.
Conclusion Our proposed system can support the training of inexperienced doctors, as well as enriching the knowledge of experienced doctors in endoscopy.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We would like to thank Editage (www.editage.com) for English language editing.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Endoscopic images obtained from October 2014 to January 2015 was used to establish the artificial intelligence (AI) system for the diagnosis of the disease range of gastric cancer. Those images were anonymized for the sake of personal information is not specified. This study was approved by the ethics committee of the Asahi University Hospital (registration number: 2020-05-01) and was conducted in accordance with the Helsinki Declaration of the World Medical Association. In this study, advanced expertise was required for processing images and making diagnostic algorithms. Therefore, all patients or the public were not involved in the design, conduct, reporting, and dissemination plans of our research.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclosures: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Data Availability
All data relevant to the study are included in the article.
